Equine tetanus immunoglobulin(F(ab')2)( Lanzhou Institute Of Biological Products)
马破伤风免疫球蛋白F(ab')2（兰州生物制品研究所）
Report date: 2023/10/27 17:51:14
Base Information
Drug NameEquine tetanus immunoglobulin(F(ab')2)( Lanzhou Institute Of Biological Products)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A